Titlebook: Clinical Trials in Latin America: Where Ethics and Business Clash; Nuria Homedes,Antonio Ugalde Book 2014 Springer International Publishin

积聚

书目名称Clinical Trials in Latin America: Where Ethics and Business Clash影响因子(影响力)




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash影响因子(影响力)学科排名




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash网络公开度




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash网络公开度学科排名




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash被引频次




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash被引频次学科排名




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash年度引用




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash年度引用学科排名




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash读者反馈




书目名称Clinical Trials in Latin America: Where Ethics and Business Clash读者反馈学科排名

无目标

Book 2014 Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​        

否认

Nigel Hoschke,Don C. Price,D. Andrew Scott, Brazil, Costa Rica, Mexico and Peru) where about 80 % of all clinical trials in the region take place and the circumstances that have left some clinical research participants insufficiently protected. A very brief summary of the highlights of each chapter is included.

辩论

crease

Book 2014al information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines

tendinitis

tendinitis

Globalization and Clinical Research in Latin America,of the industry while protecting the rights of clinical trial participants. Using regional information, the authors question if the Latin American context guarantees the protection of the human rights of the participants and their communities, and the integrity of scientific inquiry. The consequence

卷发

The Regulatory Framework and Case Studies from Argentina,ties and informed journalists, this chapter describes cases where researchers failed to obtain informed consent, duplicated patient records, and violated inclusion and exclusion criteria. The studies that have generated controversy were financed by multinational companies and involved treatments for

Hyperlipidemia

粉笔